 Home > Specialty Chemicals > Ceftazidime pentahydrate for Sale > Fast Delivery High Purity Ceftazidime CAS 78439-06-2 Factory Price Good After-Sale

Fast Delivery High Purity Ceftazidime CAS 78439-06-2 Factory Price Good After-Sale buy - large image1

Fast Delivery High Purity Ceftazidime CAS 78439-06-2 Factory Price Good After-Sale buy - image1

Fast Delivery High Purity Ceftazidime CAS 78439-06-2 Factory Price Good After-Sale buy - image2

Fast Delivery High Purity Ceftazidime CAS 78439-06-2 Factory Price Good After-Sale buy - image3

Fast Delivery High Purity Ceftazidime CAS 78439-06-2 Factory Price Good After-Sale buy - image4

Fast Delivery High Purity Ceftazidime CAS 78439-06-2 Factory Price Good After-Sale

Name: Fast Delivery High Purity Ceftazidime CAS 78439-06-2 Factory Price Good After-Sale
Brand: WANWEI
Price: 55 USD
Availability: InStock

1 Inquiries

Unit Price:

$55-60/KG FOB

Get Latest Price 

CAS No.:

78439-06-2

Grade:

Industrial Grade

Content:

99%

Port:

Shanghai

Brand:

WANWEI

Packaging:

25kg/Cardboard Drum

Price valid (until):

2026-06-18

Contact Supplier

 Chat Now

Changsha Wanwei Technology Co., Ltd.

Company Type:

Trader

Location:

China

Qualification:

Main Products:

Tirzepatide,Retatrutide,Semaglutide

 Visit Store

Product Description
Seller Information
Inquiry History

Description

Product Detail

*Product Photos

Shop N-Ethyl-3-cyano-4-methyl-6-hydroxy-2-pyridone CAS 29097-12-9 Factory Direct Supply High Quality Low Price-Detailed Image 1

Product Introduction

Item	Ceftazidime
Cas No.	78439-06-2
Purity	>99

1. Product Overview

Ceftazidime (CAS 78439-06-2) is a semi-synthetic third-generation cephalosporin antibiotic, with the chemical name (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[[1,3,5-triazin-2,4-diamino]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid trihydrate. As a broad-spectrum antibiotic widely used in clinical practice, it is highly recognized for its potent antibacterial activity against Gram-negative bacteria (including Pseudomonas aeruginosa) and inhibitory effects on some Gram-positive bacteria, making it a key pharmaceutical raw material in the chemical and pharmaceutical industry.

2. Product Functions & Mechanism

Ceftazidime exerts bactericidal effects primarily by inhibiting the biosynthesis of bacterial cell walls. Its mechanism of action targets penicillin-binding proteins (PBPs) on the bacterial cell membrane; binding to PBPs blocks the cross-linking reaction of bacterial cell wall peptidoglycan, leading to defective cell walls, loss of morphological integrity, and eventual bacterial death due to osmotic pressure rupture.

The product boasts three core functional advantages:

Broad-Spectrum Antibacterial Activity: Highly sensitive to common Gram-negative bacteria such as Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Proteus vulgaris, while also inhibiting some Gram-positive bacteria including Streptococcus pneumoniae and Streptococcus pyogenes.
Strong Antibacterial Potency: Highly stable against β-lactamases, resistant to hydrolysis by bacterial enzymes, making it suitable for treating infections caused by multi-drug resistant bacteria.
Proven Clinical Efficacy: Rapidly penetrates bacterial cell membranes to reach effective bactericidal concentrations at infection sites, with quick onset of action and short treatment courses.

Pharmacologically, Ceftazidime is rapidly absorbed after intravenous or intramuscular injection, with wide distribution in various tissues and organs including the respiratory tract, urinary system, biliary tract, bones, and joints. It can also cross the blood-brain barrier, making it applicable for the treatment of central nervous system infections. With a half-life of approximately 1.5-2 hours, it is mainly excreted via the kidneys, requiring no dosage adjustment for patients with normal renal function and ensuring high safety in use.

3. Application Scenarios

As a high-purity pharmaceutical raw material, Ceftazidime is widely used in pharmaceutical, chemical, and related fields, with core applications including:

Pharmaceutical Formulation Production: Core raw material for manufacturing clinical drugs such as Ceftazidime for injection, Ceftazidime-Sulbactam sodium combination preparations, and Ceftazidime-Avibactam sodium, suitable for large-scale production of antibiotics by pharmaceutical enterprises.
Clinical Treatment: Primarily used for treating severe infections caused by susceptible bacteria, including respiratory tract infections (pneumonia, bronchitis, lung abscess), urinary system infections (pyelonephritis, cystitis, prostatitis), biliary tract infections (cholecystitis, cholangitis), abdominal infections (peritonitis, abdominal abscess), skin and soft tissue infections, bone and joint infections, sepsis, and central nervous system infections. Particularly effective for treating infections in immunocompromised patients.
Veterinary Applications: After appropriate formulation processing, it can be used to treat bacterial infections in livestock and poultry, such as Escherichia coli disease in chickens, serositis in ducks, and pleuropneumonia in pigs, effectively controlling the spread of animal diseases and improving breeding survival rates.
Scientific Research: Serves as a standard or reference substance in microbiology, pharmacology, clinical medicine, and other research fields, providing basic raw material support for antibacterial drug development and bacterial resistance research.

4. Storage Requirements

To ensure product quality and stability, strict adherence to the following storage requirements is essential:

Storage Environment: Store in a cool, dry, and well-ventilated warehouse, away from direct sunlight, high temperature, and humid conditions. Maintain storage temperature at 2-8℃ (refrigerated), and avoid mixing with oxidants, acids, alkalis, and other corrosive substances.
Packaging Protection: The product is packaged in a double-layer sealed design (aluminum foil bag + paper drum). Ensure packaging integrity during storage to prevent moisture absorption, caking, and contamination. Use opened packages promptly; reseal and refrigerate unused portions to avoid oxidation and deterioration from air exposure.
Transportation Conditions: Adopt refrigerated transportation to avoid severe vibration and extrusion, preventing packaging damage. Keep away from fire and heat sources during transportation to ensure compliance with temperature requirements.
Shelf Life: Under strict adherence to the above storage conditions, the product has a shelf life of 2 years (calculated from the production date). Expired products must pass re-inspection before use; non-qualified products are strictly prohibited from production or clinical application.

5. Product Advantages

Our factory-supplied Ceftazidime (CAS 78439-06-2) offers core advantages including high purity (≥99.0%), factory direct supply, competitive pricing, and fast delivery. Produced in strict accordance with USP/EP/BP/CP standards, each batch undergoes multiple quality inspections to ensure high purity, low impurities, and excellent stability. We provide flexible packaging specifications and comprehensive after-sales service, supporting rapid delivery for bulk orders. Suitable for pharmaceutical enterprises, research institutions, and chemical companies, it is an ideal choice for foreign trade export and domestic production needs.

Shop N-Ethyl-3-cyano-4-methyl-6-hydroxy-2-pyridone CAS 29097-12-9 Factory Direct Supply High Quality Low Price-Detailed Image 10

Basic Info

Product Name:

Ceftazidime pentahydrate

Other Name:

Pyridinium,1-[[(6R,7R)-7-[[(2Z)-(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-,inner salt,hydrate (1:5);Pyridinium,1-[[7-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-,inner salt,pentahydrate,[6R-[6α,7β(Z)]]-;Pyridinium,1-[[(6R,7R)-7-[[(2Z)-(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-,inner salt,pentahydrate;Ceftazidime pentahydrate;Glazidim;Starcef 1;Cefidime;Ceftadizim

CAS No.:

78439-06-2

Molecular Formula:

C22H22N6O7S2.5H2O

InChIKeys:

InChIKey=NMVPEQXCMGEDNH-TZVUEUGBSA-N

Molecular Weight:

636.65

Exact Mass:

546.099121

EC Number:

276-715-9

HScode:

29419000

Categories:

Characteristics

PSA:

244.76000

XLogP3:

-2.84

Appearance:

white to cream-colored crystalline powder

Melting Point:

>1500C (dec.)

Water Solubility:

Sparingly soluble in aqueous solution

Storage Conditions:

2-8°C

See More Ceftazidime pentahydrate Properties 

Hazard Identification

Classification of the substance or mixture

Skin sensitization, Category 1

Respiratory sensitization, Category 1

GHS label elements, including precautionary statements

Precautionary statement(s)
Pictogram(s)
Signal word	Danger
Hazard statement(s)	H317 May cause an allergic skin reaction H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled
Prevention	P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/... P284 [In case of inadequate ventilation] wear respiratory protection.
Response	P302+P352 IF ON SKIN: Wash with plenty of water/... P333+P317 If skin irritation or rash occurs: Get medical help. P321 Specific treatment (see ... on this label). P362+P364 Take off contaminated clothing and wash it before reuse. P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342+P316 If experiencing respiratory symptoms: Get emergency medical help immediately.
Storage	none
Disposal	P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

Other hazards which do not result in classification

no data available

Handling and Storage

Precautions for safe handling

Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

Conditions for safe storage, including any incompatibilities

Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

See More Ceftazidime pentahydrate Safety Data Sheet 

Seller Information

Business Type:
Trader

Main Products:
Tirzepatide,Retatrutide,Semaglutide

Location:
No. 2302, Changqing Road, Gaoyuan Community, Laodaohe Sub-district, Kaifu District, Changsha City, Hunan Province

Payment Terms:
TT against copy of documents,D/P,L/C,D/A,TT against B/L draft before shipment,100% TT in advance

Average lead Time:
10

Total Annual Revenue:
$10 million-$25 million

Total Employees:
101-200

Year of Establishment:
2023

Changsha Wanwei Technology Co., Ltd. has been deeply engaged in the biopharmaceutical industry for over 20 years and stands as a global leader in the metabolic disease drug sector. Leveraging its integrated end-to-end capabilities covering "R&D, production, and commercialization" as well as profound industry expertise, the company firmly ranks among the top tier of the global biopharmaceutical industry. Its core products include multiple key varieties such as Semaglutide, Tirzepatide, Retatrutide, and Cagrilintide.
Eighty percent of the members in the company's core team possess over 15 years of experience in metabolic drug R&D. Many of them have led the launch of internationally blockbuster antidiabetic drugs. The team has successfully facilitated the approval of 12 innovative drugs, among which 5 have become top 50 best-selling prescription drugs globally. This has enabled the company to establish an irreplicable technical and experiential barrier in fields such as peptide drug molecular modification and long-acting formulation development.
On the R&D front, the company has built four national-level technology platforms, including peptide molecular design and oral formulation innovation, and holds more than 300 authorized patents. Its drug R&D cycle is 30% shorter than the industry average. On the production side, it owns the world's largest intelligent base for peptide drugs, with an annual production capacity of 500 kilograms. The base complies with the triple GMP standards of China, the United States, and the European Union, and achieves a 90% self-sufficiency rate in key raw materials, ensuring stable supply to over 120 countries. Additionally, the company has passed the unannounced inspections by the FDA (U.S. Food and Drug Administration) and EMA (European Medicines Agency) for 10 consecutive years.
Currently, Semaglutide has overcome the challenge of low oral bioavailability, achieving global sales of over 15 billion US dollars within 3 years of its launch. Tirzepatide surpassed 8 billion US dollars in sales in its first year on the market. Retatrutide has entered Phase III clinical trials, while the combination therapy of Cagrilintide is in Phase II clinical development. All these products demonstrate revolutionary therapeutic value. Looking ahead, the company will invest 25% of its annual revenue in R&D, focusing on the fields of metabolism and cardiovascular diseases, and is committed to becoming a global innovation benchmark in the biopharmaceutical industry.

Inquiry History

1 Inquiries

Country	Product	Purchase Quantity	Date Posted
India	Ceftazidime pentahydrate	1 KG	Jan 13, 2024

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Supplier Name	Details
China Most Professional Factory Supply High Qulity Ceftazidime CAS 72558-82-8/78439-06-2	Pharmaceutical Grade/99	LEADER BIOCHEMICAL GROUP	Inquiry
Ceftazidime Pentahydrate CAS No.78439-06-2	Pharmaceutical grade/99	ROYAL PHARM	Inquiry
Raw Material Ceftazidime Pentahydrate Powder CAS 78439-06-2 Ceftazidime	Pharmaceutical Grade/99	Shaanxi TNJONE Pharmaceutical Co., Ltd	Inquiry

Hot Related Products



Feedback & Suggestions

Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.